Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Alamycin 300 La 300 mg Solution is a Health Canada–registered veterinary drug (DIN 02339935) held by Norbrook Laboratories Ltd., containing Oxytetracycline (Oxytetracycline Dihydrate). Health Canada lists its status as Marketed (status date 12 Jun 2026).

Health Canada registration

DIN02339935
Brand nameAlamycin 300 La
Active ingredientOxytetracycline (Oxytetracycline Dihydrate)
Strength300 mg
Dosage formSolution
RouteIntramuscular ; Subcutaneous
CompanyNorbrook Laboratories Ltd.
StatusMarketed — 12 Jun 2026
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Status and company history

Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.

DateFieldFromTo
2026-09-03StatusDormantMarketed
2026-09-03StatusDormantMarketed

Marketed Canadian products with the same active ingredient

DINProductCompanyStrengthForm
02248663Alamycin 200 LaNorbrook Laboratories Ltd.200 mgSolution

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Alamycin 300 La (DIN 02339935) marketed in Canada?

Yes. Health Canada lists DIN 02339935 as Marketed as of 12 Jun 2026.

Who holds the Canadian licence for this product?

Norbrook Laboratories Ltd. is the company of record in the Health Canada Drug Product Database.

Is the same medicine registered outside Canada?

No same-molecule registration has been matched in the 56 national registries Nexara Health tracks. Contact us to check manually.

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02339935, status date 2026-06-12. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02339935, status date 2026-06-12.

Health Canada Drug Product Database (DPD), DIN 02339935, status date 2026-06-12. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.